A Comparison of Activities of Daily Living, Physical Fitness and Quality of Life in Obese and Healthy Adolescents

May 2, 2020 updated by: Ebru Calik Kutukcu, Hacettepe University
It is known that activities of daily living, physical fitness, exercise capacity and quality of life are affected by the obesity. It is aimed to determine the effects obesity on daily living activities, physical fitness, exercise capacity and quality of life in obese adolescents compared to healthy subjects in this study. The relationship between these parameters and the activities of daily living which are less studied in obese adolescents will be evaluated.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Obesity among children, adolescents and adults has emerged as one of the most serious public health problems in the 21st century. There has been a significant decrease in the exercise capacity, physical fitness and activities of daily living of children and adolescents with the increase in the prevalence of obesity over the last decade. Obesity can cause not only health problems but also psychological effects. This situation have negative effects on the quality of life. The effect of these parameters on healthy individuals and obese adolescents will be demonstrated by this study and will guide the rehabilitation of obese adolescents.

Study Type

Observational

Enrollment (Actual)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Samanpazari
      • Ankara, Samanpazari, Turkey, 06100
        • Hacettepe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

15 obese adolescents, 15 obese adolescent adolescents and 15 healthy female adolescents and 15 healthy male adolescents compatible with age and sex will be recruited from obese adolescents according to the BMI reference system.

Description

Inclusion Criteria:

Healthy group:

  • Being normal weight according to BMI reference system,
  • Being between the ages of 10-18 and volunteer to participate in the research,
  • Being able to walk and cooperate

Obese Group:

  • Obesity diagnosis according to BMI reference system,
  • Being between the ages of 10-18 and volunteer to participate in the research,
  • Being able to walk and cooperate.

Exclusion Criteria:

Healthy Group:

  • Comorbidities that may affect exercise performance and other physical tests,
  • Having cardiovascular problems, musculoskeletal and neurological disease,
  • Having cognitive or motor limitation or other chronic diseases.

Obese Group:

  • Having a neurological disease or other clinical diagnosis that may affect cognitive status,
  • Having musculoskeletal and neurological diseases, symptomatic heart disease, lung disease, diabetes, hypertension and malignant disease that may affect exercise performance,
  • Using medication that affects appetite and weight.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Obese Group (Girl)
Diagnosed with the obesity according to body mass index reference system, being 10-18 years old, being volunteer for the research and able to walk and cooperate are the inclusion criteria.Diagnosed with a neurological disease or another clinical diagnosis that may affect the cognitive state, musculoskeletal and neurological disease, symptomatic heart disease, lung disease, diabetes, hypertension and malignant disease, which may affect the performance of exercise and using the drug that affects appetite and weight are the exclusion criteria.
Modified Shuttle Walk Test
Obese Group (Boy)
Diagnosed with the obesity according to body mass index reference system, being 10-18 years old, being volunteer for the research and able to walk and cooperate are the inclusion criteria. Diagnosed with a neurological disease or another clinical diagnosis that may affect the cognitive state, musculoskeletal and neurological disease, symptomatic heart disease, lung disease, diabetes, hypertension and malignant disease, which may affect the performance of exercise and using the drug that affects appetite and weight are the exclusion criteria.
Modified Shuttle Walk Test
Control Group (Girl)
Being normal weight according to body mass index reference system, being 10-18 years old, being volunteer for the research and able to walk and cooperate are the inclusion criteria. Having comorbidities which may affect exercise performance and other physical tests, diagnosed with the cardiovascular problems, musculoskeletal and neurological diseases, cognitive or motor limitation or other chronic diseases are exclusion criteria.
Modified Shuttle Walk Test
Control Group (Boy)
Being normal weight according to body mass index reference system, being 10-18 years old, being volunteer for the research and able to walk and cooperate are the inclusion criteria. Having comorbidities which may affect exercise performance and other physical tests, diagnosed with the cardiovascular problems, musculoskeletal and neurological diseases, cognitive or motor limitation or other chronic diseases are exclusion criteria.
Modified Shuttle Walk Test

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Modified shuttle walk test.
Time Frame: February 2019-February 2020
Maximal exercise capacity
February 2019-February 2020

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Waist circumference, Abdominal circumference, Ratio of waist to hip
Time Frame: February 2019-February 2020
Antropometric measurements
February 2019-February 2020
Hand grip strength by hand dynamometer (Jamar).
Time Frame: February 2019-February 2020
Peripheral Muscle Strength
February 2019-February 2020
the Glittre Activities of Daily Living (ADL) Test.
Time Frame: February 2019-February 2020
Activities of daily living
February 2019-February 2020
the Munich Physical Fitness Test-MFT
Time Frame: February 2019-February 2020
Physical Fitness
February 2019-February 2020
Modified push-ups, shuttles and squats as possible for 30 seconds
Time Frame: February 2019-February 2020
Peripheral muscle endurance
February 2019-February 2020
The Pediatric Outcomes Data Collection Instrument (PODCI)
Time Frame: February 2019-February 2020
Quality of Life
February 2019-February 2020

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ceren Iskenderoglu, Physical Therapist, Hacettepe University
  • Study Chair: Deniz Inal Ince, Professor, Hacettepe University
  • Study Chair: Melda Saglam, Associate Professor, Hacettepe University
  • Study Chair: Naciye Vardar Yagli, Associate Professor, Hacettepe University
  • Study Chair: Hazal Sonbahar Ulu, MSc, Hacettepe University
  • Study Chair: Melis Pehlivanturk Kizilkan, MD, Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2019

Primary Completion (Actual)

April 1, 2020

Study Completion (Actual)

April 1, 2020

Study Registration Dates

First Submitted

December 13, 2019

First Submitted That Met QC Criteria

December 13, 2019

First Posted (Actual)

December 17, 2019

Study Record Updates

Last Update Posted (Actual)

May 5, 2020

Last Update Submitted That Met QC Criteria

May 2, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Exercise Capacity

Subscribe